Scientific Resources
Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.
Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.
Found 32 Results
Concurrent Pembrolizumab with AVD for Untreated Classical Hodgkin Lymphoma
December 13, 2021 | Abstract
Profiling of Circulating Tumor DNA for Noninvasive Disease Detection, Risk Stratification, and MRD Monitoring in Patients with CNS Lymphoma
December 13, 2021 | Abstract
Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-Cell Lymphoma: Preliminary Results and Correlatives of Response to Acalabrutinib
December 13, 2021 | Abstract
Phased variants improve DLBCL minimal residual disease detection at the end of therapy
June 3, 2021 | Poster
Leveraging Phased Variants for Personalized Minimal Residual Disease Detection in Localized Non-Small Cell Lung Cancer
June 3, 2021 | Poster
Integrating genomic features for non-invasive early lung cancer detection
March 25, 2020 | Manuscript